• Abbott Laboratories and Siemens Healthcare have the largest cardiac marker tests available in the market.
• There are more than 5 cardiac marker tests available in the kitty of Abbott Laboratories and Siemens Healthcare.
• In 2012, Response Biomedical cardiovascular product sales in double digits.
• Beckman Coulter announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System
Point of Care Testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive. Cardiac Marker analyzer represents a paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use. This diagnostic platform that helps physicians identifies several critical health conditions, including heart failure and myocardial infarction and reduces the time to diagnosis by hours.
This 62 page report contains 3 Figures and 14 Tables provides a comprehensive analysis of the emerging cardiac markers analyzer segments, including their comparative tests analysis, competitive product analysis, product features, merger and acquisitions, distribution agreement, collaboration deals and companies analyzer sales figures.
All the 12 Cardiac Marker Analyzers in the report have been studied from 6 viewpoints.
1. Analyzer Benefits and Features
2. Net Product Sales
3. Merger & Acquisition
4. Distribution Agreement
5. Collaboration Deal
6. Licensing (Exclusive) Agreement
All the 12 Cardiac Marker Analyzer studied in the report are as follows
1. Alere Meterpro Analyzer
2. RAMP 200
3. RAMP Reader
4. The i–STAT System
5. Cobas H 232 POC System
6. Stratus CS Analyzer
7. Access 2 Immunoassay System
8. ichroma DUO Analyzer
9. DXpress Reader Analyzer
10. PATHFAST Analyzer
11. Meritas POC Analyzer
12. QL Care Analyzer
